Fibroblast growth factor 21, dislipidemia in patients with coronary artery disease and concomitant obesity

Simple item page
dc.contributor.authorIvanova, Kateryna
dc.date.accessioned2018-10-25T13:31:02Z
dc.date.available2018-10-25T13:31:02Z
dc.date.issued2018-09-26
dc.description.abstractRecent studies have revealed that fibroblast growth factor 21 (FGF21) plays important role in energy metabolism regulation. FGF21 contributes to many age-related metabolic disorders, e.g. atherosclerosis, obesity, type 2 diabetes, and some cardiovascular diseasesru_RU
dc.identifier.citationIvanova K. V. Fibroblast growth factor 21, dislipidemia in patients with coronary artery disease and concomitant obesity / K. V. Ivanova // Український кардіологічний журнал. – 2018. – Додаток 1 : ХІХ Національний конгрес кардіологів України: тези доповідей, Київ, 26–28 вересня 2018. – С. 56.ru_RU
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/20667
dc.language.isoenru_RU
dc.subjectfibroblast growth factor 21ru_RU
dc.subjectdyslipidemiaru_RU
dc.subjectcoronary artery diseaseru_RU
dc.titleFibroblast growth factor 21, dislipidemia in patients with coronary artery disease and concomitant obesityru_RU
dc.typeThesisru_RU

Files

Original bundle

Now showing 1 - 2 of 2
Thumbnail Image
Name:
конгресс-pages-15.pdf
Size:
90.06 KB
Format:
Adobe Portable Document Format
Description:
Download
Thumbnail Image
Name:
укж.pdf
Size:
144.74 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
11.51 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Наукові праці. Кафедра загальної практики – сімейної медицини та внутрішніх хвороб